Table 2.
Variable | β | P-value | Odds Ratio (95% CI) |
---|---|---|---|
Sex | −1.916 | <0.001 | 0.147 (0.099–0.218) |
Age | −0.548 | 0.006 | 1.024 (1.007–1.042) |
Comorbidities | |||
Hypertension | 0.276 | 0.089 | 1.318 (0.958–1.814) |
Coronary artery disease | 0.315 | 0.093 | 1.370 (0.949–1.977) |
Cerebrovascular disease | 0.365 | 0.070 | 1.440 (0.971–2.138) |
Diabetes duration | 0.004 | 0.004 | 1.004 (1.001–1.006) |
Family history of carcinomas | 0.132 | 0.572 | 1.141 (0.722–1.805) |
Smoking | 0.729 | <0.001 | 2.074 (1.487–2.893) |
BMI | −0.462 | <0.001 | 0.630 (0.486–0.816) |
Use of blood glucose-lowering drugs | |||
Insulin | 0.706 | <0.001 | 2.207 (1.366–3.006) |
Thiazolidinediones | −0.557 | 0.497 | 0.573 (0.115–2.861) |
Alpha glucosidase inhibitors | −0.026 | 0.921 | 0.975 (0.586–1.622) |
Sulfonylureas | −0.248 | 0.318 | 0.780 (0.479–1.270) |
Metformin | −0.045 | 0.838 | 0.956 (0.623–1.468) |
Combination of oral drugs and insulin | 0.572 | 0.154 | 1.771 (0.807–3.886) |
Combination of oral drugs | −0.238 | 0.392 | 0.788 (0.458–1.359) |
Abbreviation: BMI, body mass index.